Jiangxi Fushine Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Jiangxi Fushine Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 67.8%. Its total assets and total liabilities are CN¥4.6B and CN¥2.3B respectively.
Key information
67.8%
Debt to equity ratio
CN¥1.62b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥676.89m |
| Equity | CN¥2.39b |
| Total liabilities | CN¥2.26b |
| Total assets | CN¥4.65b |
Recent financial health updates
Recent updates
There's Reason For Concern Over Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Massive 28% Price Jump
Oct 04
Is Jiangxi Fushine Pharmaceutical (SZSE:300497) A Risky Investment?
Jun 12What Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) 26% Share Price Gain Is Not Telling You
May 06Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Business And Shares Still Trailing The Industry
Feb 27Financial Position Analysis
Short Term Liabilities: 300497's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 300497's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥808.9M).
Debt to Equity History and Analysis
Debt Level: 300497's net debt to equity ratio (39.4%) is considered satisfactory.
Reducing Debt: 300497's debt to equity ratio has increased from 60.8% to 67.8% over the past 5 years.
Debt Coverage: 300497's debt is not well covered by operating cash flow (6.3%).
Interest Coverage: Insufficient data to determine if 300497's interest payments on its debt are well covered by EBIT.